Emergency Medicine

Causes of suicidal ideation — Evaluation

Pathway

E-MOTIVE

Study

EARLY TAVR

Study

Early TIPS for variceal hemorrhage

Study

EARLY-UNLOAD

Study

EARLYDRAIN

Study

EASE

Study

EAST-AFNET 4

Study

ECASS III

Study

ECHOGUIDE

Study

EchoPAIN

Study

ECLA PHRI COLCOVID

Study

ECLS-SHOCK (1-year follow-up)

Study

ECLS-SHOCK (original research)

Study

ECST

Study

Ectopic pregnancy

Disease

Effect of Screen Time on Recovery From Concussion

Study

EFFECTS

Study

EINSTEIN-PE

Study

EIRPI

Study

ELAIN

Study

ELAIN FOLLOW-UP

Study

ELDERCARE-AF (subanalysis)

Study

Electrical alternans

Finding

Electromechanical dissociation

Finding

ELIXA

Study

EMBOLISE

Study

EMBRACE (ambulatory ECG monitoring)

Study

EMERGE

Study

EMMA

Study

EMPACT-MI

Study

EMPACTA

Study

EMPEROR-Preserved

Study

EMPEROR-Reduced

Study

EMPHASIS-HF

Study

EMPULSE

Study

ENGAGE AF-TIMI 48 (edoxaban 30 mg)

Study

ENGAGE AF-TIMI 48 (edoxaban 60 mg)

Study

ENGAGE AF-TIMI 48 (post-hoc analysis, edoxaban 60 mg vs. 30 mg)

Study

ENGAGE AF-TIMI 48 (post-hoc analysis, edoxaban vs. warfarin)

Study

ENRICH

Study

ENTRUST-AF PCI

Study

EPCAT I

Study

EPCAT II

Study

EPHESUS

Study

EPIC-CAD

Study

EPIC-HR

Study

EPIPAN

Study

EPO-TBI (6-month outcomes)

Study

EPO-TBI (long-term follow-up)

Study

ERADICATE

Study

ESCAPe (community-acquired pneumonia)

Study

ESCAPE (heart failure)

Study

Esophageal perforation

Disease

ESPRIT

Study

ESSENCE

Study

EVEREST-Outcomes

Study

Evolut low risk

Study

EX-DHF

Study

Exercise-associated hyponatremia

Disease

EXTEND

Study

EXTEND-IA

Study

EXTEND-IA TNK

Study

Lower extremity arterial injury — Evaluation and management

Pathway